High Court Directed Government to Address Price Disparities in Non-Scheduled Drug Formulations. Wide Price Variation Among Brands of Same Medicine Held to be a Matter of Public Concern Requiring Government Intervention Under Rule 10(b) of Drugs (Prices Control) Order, 1995.
23 Jun 2010The writ petition, filed as a public interest litigation, brought to the court's attention the stark and arbitrary price differences in identical drug...
